National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant platelet factor 4
A recombinant form of the endogenous chemokine platelet factor 4 with potential antiangiogenesis and antineoplastic activities. As a heparin-binding tetramer, recombinant platelet factor 4 inhibits growth factor-stimulated endothelial cell proliferation, migration, and angiogenesis; it has been shown that this agent inhibits fibroblast growth factor 2 (FGF2) angiogenic activity downstream from the FGF2 receptor. Its activity is antagonized by heparin. Recombinant platelet factor 4 may also directly inhibit the proliferation of some tumor cell types. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:CXC-chemokine PF-4
CXCL4
platelet factor 4
recombinant human platelet factor 4
Acronyms:rhPF4
rPF4
rPF4



Previous:recombinant macrophage colony-stimulating factor, recombinant MAGE-3.1 antigen, recombinant modified vaccinia Ankara-5T4 vaccine, recombinant nematode anticoagulant protein c2, recombinant parathyroid hormone
Next:recombinant soluble human CD4 protein, recombinant thyroid-stimulating hormone, recombinant thyrotropin alfa, recombinant tissue plasminogen activator, recombinant TNF-related apoptosis-inducing ligand

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov